Merck · 3 hours ago
2026 Future Talent Program – Discovery Immunology – Co-op (Cambridge, MA)
Merck is a global health care leader with a diversified portfolio of prescription medicines, vaccines, and animal health products. They are seeking co-op candidates for their Discovery Immunology group in Cambridge, where students will contribute to drug discovery efforts and learn key techniques in immunology and molecular biology. This role offers a collaborative environment aimed at developing new technologies that drive therapeutic development.
BiotechnologyHealth CareMedicalPharmaceutical
Responsibilities
Co-op students will be part of a highly collaborative and innovative scientific culture with the ultimate goal of learning new biology and chemistry and establishing new technologies that drive therapeutic development
Co-op students will work within a diverse group studying the role of novel targets in the context of inflammatory and autoimmune indications
Qualification
Required
Must be currently enrolled in school (through the co-op term) as an undergraduate or graduate student majoring in biological sciences or a related field
Must be available for a 4–6-month period starting mid-2026
Must have availability to work full-time on site in Cambridge, MA
Preferred
Basic knowledge of cell biology, immunology, molecular biology, and/or related wet lab techniques
Prior experience with mammalian cell culture, flow cytometry and/or immunoassays
Highly motivated and driven and willing to take initiative to learn new science
Strong team player
Excellent oral and written communication skills
Comfortable using a PC computer and proficient in Windows-based operating systems and basic applications, such as spreadsheets and databases
3.2 GPA or higher
Company
Merck
Merck is a biopharmaceutical company that offers medicines and vaccines for various diseases.
Funding
Current Stage
Public CompanyTotal Funding
$5.59MKey Investors
Private Capital AdvisorsGavi, the Vaccine Alliance
2018-11-25Post Ipo Equity· $0.59M
2016-01-21Series Unknown· $5M
1980-12-19IPO
Leadership Team
Recent News
Company data provided by crunchbase